کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8449242 | 1547609 | 2008 | 5 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
تحقیقات سرطان
پیش نمایش صفحه اول مقاله

چکیده انگلیسی
Monoclonal antibodies against EGFR represent one of the most important recent advancements in the treatment of colorectal cancer. Anyway, to date, only a subset of patients can really take advantage from this kind of drugs. The identification of predictive factors that are able to stratify patients who potentially can benefit by these biological treatment, is an important aim of anticancer research both in clinical and in pre-clinical fields. Many studies evaluating classical IHC analysis of protein expression failed in this purpose. So in the last years there was the need to look forward to a new class of molecular predictive factors. Indeed a number of biomarkers have been evaluated in their potential to predict the response to anti-EGFR-based therapies. These include marker related to EGFR amplification, activation and phosphorylation, EGFR polymorphisms, but also markers related to Ras/Raf/MAPK and the PI3K/Akt signalling pathways and angiogenesis. This review will focus the attention to these new genetic and molecular markers.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Cancer Supplements - Volume 6, Issue 14, October 2008, Pages 86-90
Journal: European Journal of Cancer Supplements - Volume 6, Issue 14, October 2008, Pages 86-90
نویسندگان
Daniele Santini, Francesco Pantano, Bruno Vincenzi, Fotios Loupakis, Michele Caraglia, Alfredo Falcone, Giuseppe Tonini,